Authors:
BLOCK GA
HULBERTSHEARON TE
LEVIN NW
PORT FK
Citation: Ga. Block et al., ASSOCIATION OF SERUM PHOSPHORUS AND CALCIUM X PHOSPHATE PRODUCT WITH MORTALITY RISK IN CHRONIC-HEMODIALYSIS PATIENTS - A NATIONAL STUDY, American journal of kidney diseases, 31(4), 1998, pp. 607-617
Citation: Ga. Block et al., THE SUBSTANCE-P RECEPTOR ANTAGONIST L-754,030 (MK-0869) IS INEFFECTIVE IN THE TREATMENT OF POSTHERPETIC NEURALGIA, Neurology, 50(4), 1998, pp. 4084-4084
Citation: Ba. Norman et al., 2-PERIOD CROSSOVER COMPARISON OF RIZATRIPTAN 5 MG AND 10 MG TO SUMATRIPTAN 25 MG AND 50 MG FOR THE ACUTE TREATMENT OF MIGRAINE, Neurology, 50(4), 1998, pp. 46005-46005
Authors:
SANTANELLO NC
POLIS AB
HARTMAIER SL
BLOCK GA
SILBERSTEIN SD
Citation: Nc. Santanello et al., RESPONSE OF A 24-H MIGRAINE QUALITY-OF-LIFE QUESTIONNAIRE IN A CLINICAL-TRIAL, Quality of life research, 6(5), 1997, pp. 74-74
Authors:
SANTANELLO NC
POLIS AB
HARTMAIER SL
KRAMER MS
BLOCK GA
SILBERSTEIN SD
Citation: Nc. Santanello et al., IMPROVEMENT IN MIGRAINE-SPECIFIC QUALITY-OF-LIFE IN A CLINICAL-TRIAL OF RIZATRIPTAN, Cephalalgia, 17(8), 1997, pp. 867-872
Citation: Ga. Block, FINAL RESULTS FROM A DOSE-ESCALATING SAFETY AND TOLERANCE STUDY OF THE NONCOMPETITIVE NMDA ANTAGONIST CNS1102 IN PATIENTS WITH ACUTE CEREBRAL-ISCHEMIA, Stroke, 26(1), 1995, pp. 185-185
Authors:
SRAMEK JJ
BLOCK GA
REINES SA
SAWIN SF
BARCHOWSKY A
CUTLER NR
Citation: Jj. Sramek et al., A MULTIPLE-DOSE SAFETY TRIAL OF EPTASTIGMINE IN ALZHEIMERS-DISEASE, WITH PHARMACODYNAMIC OBSERVATIONS OF RED-BLOOD-CELL CHOLINESTERASE, Life sciences, 56(5), 1994, pp. 319-326